A Case of Multisystem Inflammatory Syndrome in a 12-Year-old Male After COVID-19 mRNA Vaccine
Rumeysa Yalçinkaya, Fatma Nur Öz, Meltem Polat, Berna Uçan, Türkan Aydin Teke, Ayşe Kaman, Suna Özdem, Zeynep Savaş Şen, Rüveyda Gümüşer Cinni, Gönül Tanir
Abstract
The pathophysiology of multisystem inflammatory syndrome (MIS) in children (MIS-C) is unknown. It occurs several weeks after COVID-19 infection or exposure; however, MIS is rarely reported after COVID-19 vaccination, and cases are mostly in adults. Herein, we present a 12-year-old male who had no prior COVID-19 infection or exposure and developed MIS-C after his first dose of COVID-19 mRNA vaccine.
Topics & Concepts
MedicineImmunologyPathophysiologyMultisystem diseaseImmune systemInflammationVaccinationDiseaseMessenger RNAAntibodySystemic inflammatory response syndromeImmunityChemokineCytokineVirologyImmunopathologyImmunogenicityInflammatory responseKawasaki Disease and Coronary ComplicationsSARS-CoV-2 and COVID-19 ResearchLymphadenopathy Diagnosis and Analysis